Vitestro revealed the name of its autonomous blood drawing device: Aletta, the first autonomous robotic device.
Aletta is named in honor of Dr. Aletta Jacobs, a Dutch physician whose groundbreaking work reshaped modern healthcare. As the first female doctor in the Netherlands, Dr. Jacobs was a relentless advocate for medical advancement, accessibility, and patient well-being. Inspired by her vision, Aletta embodies these same values—trust, empathy, innovation, and collaboration—while paying tribute to Vitestro’s Dutch heritage and its mission to advance phlebotomy worldwide.
Aletta is the first and only Autonomous Robotic Phlebotomy Device (ARPD), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection.
Aletta’s capabilities include:
• AI-powered Doppler ultrasound and imaging technology.
• Robotic-controlled needle insertion for consistent, accurate blood draws.
• Fully automated blood collection to reduce variability and human dependence.
• Seamlessly fits into hospital and laboratory workflows.
• Clinically validated safety and comfort in over 4,000 patients, with pain levels comparable to or lower than manual blood draws.
Following its CE-marking and initial commercial launch in Europe, Vitestro is preparing for broader adoption of Aletta across hospitals and laboratories throughout the region. The company is also working towards U.S. regulatory approval and conducting a U.S.-based multi-center clinical trial in collaboration with leading academic medical centers and healthcare systems.
